4DNBSAS2C2UK
released
October 17th, 2024 at 9:12pm
Overview
Stable Genomic Modifications
None
Treatment
dTAGv-1 treatment (500.0 nM, 24.0h)
(Chemical)
Biosample Protocols
None
Biosource
Biosource Type
Immortalized cell line
Cell Line Name
Individual
Biosource Vendor
None